Skip to Main Content

Author Details

Olivier Harismendy
University of California
2003
90
31
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36344859Assessing Unique Risk Factors for COVID-19 Complications Among Cancer Patients: A Multi-ethnic Cohort Study.J Immigr Minor Health2023
37721516Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project.Cancer Res Commun2023
37173324Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response.Nat Commun2023
36922359Bilateral mastectomy associated with higher breast cancer mortality among patients with estrogen receptor positive progesterone receptor negative localized breast cancer.Chin Clin Oncol2023
36435650Risk factors for breast cancer mortality after ductal carcinoma in situ diagnosis differ from those for invasive recurrence.Surgery2023
36596361Whole-genome CRISPR screening identifies PI3K/AKT as a downstream component of the oncogenic GNAQ-focal adhesion kinase signaling circuitry.J Biol Chem2023
34426440Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response.Clin Cancer Res2022
35348771COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry.Oncologist2022
35715421Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer.NPJ Syst Biol Appl2022
35849291Co-Localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series.Ann Surg Oncol2022
36575447Accurate genome-wide genotyping from archival tissue to explore the contribution of common genetic variants to pre-cancer outcomes.J Transl Med2022
36064993ASO Visual Abstract: Co-localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series.Ann Surg Oncol2022
36194164A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck.Clin Cancer Res2022
35977482Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment.Cell Rep2022
35284308Histopathological growth distribution of ductal carcinoma in situ: tumor size is not "one size fits all".Gland Surg2022
35027560The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ.NPJ Breast Cancer2022
35027548Stem-like breast cancer cells in the activated state resist genetic stress via TGFBI-ZEB1.NPJ Breast Cancer2022
34618239Large and diffuse ductal carcinoma in situ: potentially lethal subtypes of "preinvasive" disease.Int J Clin Oncol2022
33383047Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis.Life Sci2021
33603171Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis.Oncogene2021
34250403Synchronous, Yet Genomically Distinct, GIST Offer New Insights Into Precise Targeting of Tumor Driver Mutations.JCO Precis Oncol2021
34285288Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers.Sci Rep2021
34255745Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions.JCI Insight2021
33373444Genomics Links Inflammation With Neurocognitive Impairment in Children Living With Human Immunodeficiency Virus Type-1.J Infect Dis2021
33168968Deciphering cell-cell interactions and communication from gene expression.Nat Rev Genet2021
32493703HER2-Overexpressing Ductal Carcinoma <i>In Situ</i> Associated with Increased Risk of Ipsilateral Invasive Recurrence, Receptor Discordance with Recurrence.Cancer Prev Res (Phila)2020
31923184Autophagy gene haploinsufficiency drives chromosome instability, increases migration, and promotes early ovarian tumors.PLoS Genet2020
33208147Mutational profiling of micro-dissected pre-malignant lesions from archived specimens.BMC Med Genomics2020
30420444Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial.Clin Cancer Res2019
31519929HNRNPK maintains epidermal progenitor function through transcription of proliferation genes and degrading differentiation promoting mRNAs.Nat Commun2019
30869786Evaluating and sharing global genetic ancestry in biomedical datasets.J Am Med Inform Assoc2019
30923040Activation of hedgehog signaling associates with early disease progression in chronic lymphocytic leukemia.Blood2019
31171722Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy.J Biol Chem2019
30266697Prognostic Importance of Age, Tumor Location, and Tumor Grade in Grade II Astrocytomas: An Integrated Analysis of the Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results Database.World Neurosurg2019
29309983Interaction Between the Contributions of Tumor Location, Tumor Grade, and Patient Age to the Survival Benefit Associated with Gross Total Resection.World Neurosurg2018
32913983Genomic Landscape of Appendiceal Neoplasms.JCO Precis Oncol2018
30217226Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.Genome Med2018
29995872Nuclear respiratory factor 1 promotes spheroid survival and mesenchymal transition in mammary epithelial cells.Oncogene2018
30290838ADAR1-mediated RNA-editing of 3'UTRs in breast cancer.Biol Res2018
30287485Integrative genomic analysis of mouse and human hepatocellular carcinoma.Proc Natl Acad Sci U S A2018
28606096Pan-cancer analysis reveals technical artifacts in TCGA germline variant calls.BMC Genomics2017
29938249Duodenal-Jejunal Flexure GI Stromal Tumor Frequently Heralds Somatic <i>NF1</i> and Notch Pathway Mutations.JCO Precis Oncol2017
28198375Haploinsufficiency networks identify targetable patterns of allelic deficiency in low mutation ovarian cancer.Nat Commun2017
28410642iPSCORE: A Resource of 222 iPSC Lines Enabling Functional Characterization of Genetic Variation across a Variety of Cell Types.Stem Cell Reports2017
28430977Deep mining heterogeneous networks of biomedical linked data to predict novel drug-target associations.Bioinformatics2017
28151979Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility.PLoS One2017
29158538PinAPL-Py: A comprehensive web-application for the analysis of CRISPR/Cas9 screens.Sci Rep2017
28724664Biochemical, Molecular, and Clinical Characterization of Succinate Dehydrogenase Subunit A Variants of Unknown Significance.Clin Cancer Res2017
27545889Nrf2 Induces IL-17D to Mediate Tumor and Virus Surveillance.Cell Rep2016
27793025Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.Oncotarget2016
  • 1 - 50 of 90

Recommended Authors

Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 1
Institute for Cancer Research, Oslo University Hospital
Career Start Year 2014
Number of shared co-authors 2
The Hospital for Sick Children
Career Start Year 2012
Number of shared co-authors 7
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 2
University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 4
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 6
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 5
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 7
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 6
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 6
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 3
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 4
University of Augsburg
Career Start Year 2004
Number of shared co-authors 4
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 1
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 5
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 9
Washington University
Career Start Year 2003
Number of shared co-authors 2
Washington University
Career Start Year 2003
Number of shared co-authors 3
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 7
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 5
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 3
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 0
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 11
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 3
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 1
The Broad Institute of Harvard and MIT
Career Start Year 1998
Number of shared co-authors 9
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 7
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 8
The Ohio State University
Career Start Year 1988
Number of shared co-authors 13

Collaborators

University of California, USA Institute for Genomic Medicine
Co-authored papers 29
Institute for Genomic Medicine, University of California San Diego
Co-authored papers 11
Department of Medicine and Moores Cancer Center, University of California San Diego
Co-authored papers 9
Universidade Federal de Sao Paulo
Co-authored papers 8
Department of Medicine and Moores Cancer Center, University of California San Diego.
Co-authored papers 7
University of California San Diego
Co-authored papers 7
University of California San Diego
Co-authored papers 7
Moores Cancer Center, University of California San Diego
Co-authored papers 7
University of California San Diego
Co-authored papers 6
Department of Pediatrics and Rady's Children's Hospital, University of California
Co-authored papers 6
University of California San Diego
Co-authored papers 5
University of California San Diego Moores Cancer Center
Co-authored papers 5
Moores Cancer Center, university of california san diego
Co-authored papers 4
Moores Cancer Center, university of california san diego
Co-authored papers 4
China Pharmaceutical University
Co-authored papers 4
Herbert Wertheim School of Public Health, University of California San Diego
Co-authored papers 4
Co-authored papers 3
University of California San Diego
Co-authored papers 3
University of Minnesota
Co-authored papers 3
University of California
Co-authored papers 3
Stanford University
Co-authored papers 3
University of California San Diego Health System
Co-authored papers 3
The Scripps Research Institute
Co-authored papers 3
University of California
Co-authored papers 3
University of California San Diego
Co-authored papers 3
University of California San Diego
Co-authored papers 3
Moores Cancer Center, university of california san diego Health System
Co-authored papers 3
University of California San Diego
Co-authored papers 3
Oregon Health & Science University
Co-authored papers 3
University of Maine
Co-authored papers 3